From Dose to Exposure: Shifting the Paradigm of Pediatric Clinical Pharmacology Research and Education.
作者信息
Morales Junior Ronaldo, Amajor Victor, Paice Kelli, Kyler Kathryn E, Hambrick H Rhodes, Pavia Kathryn E, Haynes Andrew S, Gooden Felicia, Pais Gwendolyn M, Downes Kevin J, Ramsey Laura B, Wagner Jonathan, Tang Girdwood Sonya
机构信息
Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Division of Infectious Diseases and Center for Clinical Pharmacology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
出版信息
Clin Pharmacol Ther. 2024 Sep;116(3):515-517. doi: 10.1002/cpt.3281. Epub 2024 Apr 30.
Abstract
摘要
相似文献
1
From Dose to Exposure: Shifting the Paradigm of Pediatric Clinical Pharmacology Research and Education.从剂量到暴露：转变儿科临床药理学研究与教育范式。
Clin Pharmacol Ther. 2024 Sep;116(3):515-517. doi: 10.1002/cpt.3281. Epub 2024 Apr 30.
2
Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012-2020.2012年至2020年提交给美国食品药品监督管理局的儿科药物开发试验中的剂量范围确定
J Clin Pharmacol. 2025 Aug;65(8):955-960. doi: 10.1002/jcph.70016. Epub 2025 Mar 11.
3
Advancing pediatric drug development in South Asia: Current landscape and vision for the future.推进南亚儿科药物研发：现状与未来展望。
Indian J Pharmacol. 2024 Jul 1;56(4):285-289. doi: 10.4103/ijp.ijp_396_24. Epub 2024 Sep 10.
4
Using electronic health records for clinical pharmacology research: Challenges and considerations.利用电子健康记录进行临床药理学研究：挑战与考虑。
Clin Transl Sci. 2024 Jul;17(7):e13871. doi: 10.1111/cts.13871.
5
Appraising the visibility, relevance and impacts of clinical pharmacology.评估临床药理学的可见性、相关性及影响。
Br J Clin Pharmacol. 2025 Jul;91(7):1884-1898. doi: 10.1002/bcp.70074. Epub 2025 Apr 27.
6
Clinical Pharmacology and Medication Safety: A Remote Learning Elective Designed for Senior Medical Students.临床药理学与用药安全：一门为高年级医学生设计的远程学习选修课。
Pharmacol Res Perspect. 2025 Aug;13(4):e70150. doi: 10.1002/prp2.70150.
7
Exposure Matching for Extrapolation of Efficacy in Pediatric Drug Development.儿科药物研发中疗效外推的暴露量匹配
J Clin Pharmacol. 2016 Nov;56(11):1326-1334. doi: 10.1002/jcph.744.
8
The Use of Entrustable Professional Activities in Pediatric Postgraduate Medical Education: A Systematic Review.可托付专业活动在儿科研究生医学教育中的应用：一项系统综述。
Acad Pediatr. 2022 Jan-Feb;22(1):21-28. doi: 10.1016/j.acap.2021.07.007. Epub 2021 Jul 10.
9
Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review.儿科药物研发中用于大小和年龄缩放的定量临床药理学：一项系统评价。
J Clin Pharmacol. 2015 Nov;55(11):1207-17. doi: 10.1002/jcph.555. Epub 2015 Jul 15.
10
Training clinicians in pediatric pharmacology-toxicology: the Toronto model.对临床医生进行儿科药理毒理学培训：多伦多模式。
Paediatr Drugs. 2009;11(1):60-2. doi: 10.2165/0148581-200911010-00020.
本文引用的文献
1
Current Practices in Pharmacogenomics.当前的药物基因组学实践。
Pediatr Clin North Am. 2023 Oct;70(5):995-1011. doi: 10.1016/j.pcl.2023.05.010. Epub 2023 Jul 3.
2
Genotyping for HLA Risk Alleles to Prevent Drug Hypersensitivity Reactions: Impact Analysis.用于预防药物超敏反应的HLA风险等位基因基因分型：影响分析
Pharmaceuticals (Basel). 2021 Dec 21;15(1):4. doi: 10.3390/ph15010004.
3
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease.抗英夫利昔单抗可加速清除，而增加剂量可逆转免疫原性并重新获得儿科克罗恩病的临床应答。
Aliment Pharmacol Ther. 2022 Mar;55(5):593-603. doi: 10.1111/apt.16733. Epub 2021 Dec 22.
4
Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care.药物遗传学和模型指导的精准给药在临床中的应用以改善患者护理。
Br J Clin Pharmacol. 2022 Feb;88(4):1418-1426. doi: 10.1111/bcp.14426. Epub 2020 Jul 8.
5
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.针对耐甲氧西林金黄色葡萄球菌严重感染的万古霉素治疗监测：美国卫生系统药师协会、美国传染病学会、儿科传染病学会及传染病药师学会的修订共识指南及综述
Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
6
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia.使用基于药代动力学指导剂量的羟基脲治疗镰状细胞贫血的幼儿，具有良好的临床和实验室反应。
Am J Hematol. 2019 Aug;94(8):871-879. doi: 10.1002/ajh.25510. Epub 2019 Jun 12.
7
Off-label Medication Prescribing Patterns in Pediatrics: An Update.儿科非适应证用药处方模式：最新进展
Hosp Pediatr. 2019 Mar;9(3):186-193. doi: 10.1542/hpeds.2018-0168. Epub 2019 Feb 11.
8
Clinical Pharmacology Studies in Critically Ill Children.危重症儿童的临床药理学研究
Pharm Res. 2017 Jan;34(1):7-24. doi: 10.1007/s11095-016-2033-y. Epub 2016 Sep 1.
9
Safe and effective variability-a criterion for dose individualization.安全且有效的可变性——剂量个体化的标准。
Ther Drug Monit. 2012 Oct;34(5):565-8. doi: 10.1097/FTD.0b013e31826aabc3.
10
Ten common questions (and their answers) about off-label drug use.关于药品未注册使用的十个常见问题（及其答案）。
Mayo Clin Proc. 2012 Oct;87(10):982-90. doi: 10.1016/j.mayocp.2012.04.017. Epub 2012 Aug 6.
Zotero 插件